Koers ZIVO Bioscience, Inc. Other OTC
Aandelen
ZIVO
US98978N1019
Voedselverwerking
Omzet 2024 * | 545K 510K | Omzet 2025 * | 1,51 mln. 1,41 mln. | Marktkapitalisatie | 22,7 mln. 21,23 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,48 mln. | Nettowinst (verlies) 2025 * | -8 mln. -7,48 mln. | EV/omzet 2024 * | 41,7 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 15,1 x |
K/w-verhouding 2024 * |
-2,93
x | K/w-verhouding 2025 * |
-3,68
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 59,42% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Payne
CEO | Chief Executive Officer | 76 | 19-07-13 |
Keith Marchiando
DFI | Director of Finance/CFO | 61 | 01-01-21 |
Laura Belicka
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 77 | 17-09-14 | |
Director/Board Member | 58 | 28-08-13 | |
John Payne
CEO | Chief Executive Officer | 76 | 19-07-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,20% | 7,78 mld. | |
+0,34% | 7,38 mld. | |
+10,20% | 6,52 mld. | |
-8,10% | 3,67 mld. | |
-14,57% | 1,17 mld. | |
+8,34% | 934 mln. | |
-42,27% | 879 mln. | |
-18,90% | 836 mln. | |
-16,45% | 802 mln. |